Creo Medical signs IP licence deal with CMR Surgical
24th Oct 2022 15:04
(Sharecast News) - Surgical endoscopy device company Creo Medical Group has signed a non-exclusive intellectual property licence and a royalty agreement with surgical robotics business CMR Surgical, it announced on Monday, to integrate certain aspects of Creo's technology with the 'Versius' surgical robotic system through its 'powered by Kamaptive' licensing programme.
Read moreCreo Medical ends year with revenue above forecasts
3rd Feb 2022 11:36
(Sharecast News) - Surgical endoscopy medical device company Creo Medical Group said it continued to deliver on its three-tiered 'build, buy and partner' strategy in a trading update on Thursday, saying it built momentum through "sustained commercial progress" in 2021.
Read moreCreo Medical acquires Aber Electronics for undisclosed sum
12th Nov 2021 09:38
(Sharecast News) - Medical device company Creo Medical Group has acquired power amplifier and radio frequency products manufacturer and designer Aber Electronics for an undisclosed, fixed cash consideration, plus a contingent consideration over a three-year period.
Read moreCreo Medical losses widen slightly as products progress
30th Sep 2021 10:00
(Sharecast News) - Surgical endoscopy technology company Creo Medical reported total first-half sales of £12.9m on Thursday, up from nil sales year-on-year.
Read moreCreo Medical opens new US headquarters as it focuses on market
16th Jul 2021 11:27
(Sharecast News) - Surgical endoscopy medical devices company Creo Medical Group has opened its United States headquarters at the Summit in Danbury, Connecticut, it announced on Friday.
Read moreCreo Medical buys freehold on head office and adjacent site
6th Jul 2021 09:22
(Sharecast News) - Surgical endoscopy device company Creo Medical has completed the freehold purchase of its main headquarters in Chepstow, Creo House, it announced on Tuesday.
Read moreCreo upbeat on first in-human use of MicroBlate Fine
16th Jun 2021 10:05
(Sharecast News) - Medical device company Creo Medical Group updated the market on its 510(k) US Food and Drug Administration (FDA)-cleared tissue ablation device, 'MicroBlate Fine' on Wednesday, reporting that the device was successfully used for the first in-human, minimally invasive, endoscopic ultrasound (EUS)-guided treatment in a patient with an unresectable pancreatic neuroendocrine tumour.
Read moreCreo Medical buying freehold of current Chepstow headquarters
14th Jun 2021 09:04
(Sharecast News) - Surgical endoscopy-focussed medical device company Creo Medical Group has exchanged contracts to acquire the freehold interest in the current site of its primary headquarters in Chepstow, Creo House, it announced on Monday.
Read moreCreo sales grow, losses widen as company expands
4th Jun 2021 08:58
(Sharecast News) - Surgical endoscopy-focussed medical device company Creo Medical Group reported a "strong" set of final results on Friday, with "significant" internal development and expansion despite the Covid-19 pandemic.
Read moreCreo upbeat on new data around economics of 'Speedboat Inject'
26th May 2021 12:00
(Sharecast News) - Surgical endoscopy medical device company Creo Medical announced on Wednesday that data from a new paper demonstrated that the use of its 'Speedboat Inject' product was "highly likely" to be a cost-effective strategy for treating both benign and malignant large non-pedunculated colorectal polyps (LNPCP).
Read moreCreo Medical ups FY revenues guidance after stronger-than-expected Q1 trading
19th May 2021 09:40
(Sharecast News) - Medical device company Creo Medical Group said on Wednesday that first-quarter trading had been ahead of management expectations, leading the group to upgrade guidance for its year-end revenue performance by "at least 10%".
Read moreCreo Medical ends year 'marginally ahead' of forecasts
17th Feb 2021 09:47
(Sharecast News) - Medical devices company Creo Medical Group said on Wednesday that trading for 2020 was "marginally ahead" of management expectations, with revenue rising to more than £9m, from £0.01m in 2019.
Read moreCreo Medical gets FDA clearance for 'MicroBlate Flex' device
7th Jan 2021 08:09
(Sharecast News) - Surgical endoscopy-focussed medical devices company Creo Medical Group has received 510(k) clearance from the US Food and Drug Administration (FDA) for its 'MicroBlate Flex' tissue ablation device, it announced on Thursday.
Read moreCreo upbeat on first-in-human clinical use of 'MicroBlate Fine'
9th Dec 2020 15:36
(Sharecast News) - Medical device company Creo announced the first in-human clinical use of its 'MicroBlate Fine' device, believed to be the world's smallest fine needle microwave ablation device available for clinical practice.
Read moreCreo Medical acquires Belgian GI consumables supplier Boucart Medical
3rd Nov 2020 08:58
(Sharecast News) - Medical device company Creo Medical said on Tuesday that it had acquired Belgian consumables supplier Boucart Medical as part of a deal worth up to €5.0m.
Read more